Structured Summary
Abstract
A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
MeSH Record
Classification
Broader headings
Narrower headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
7 entry terms
- Dimethylbiguanidine
- Dimethylguanylguanidine
- Glucophage
- Metformin HCl
- Metformin Hydrochloride
- HCl, Metformin
- Hydrochloride, Metformin
MeSH Record
Aspects Covered
25 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
Indexing Annotation
a hypoglycemic
MeSH Hierarchy
Tree Number
MeSH Record
NLM Classification
WK 825
AMA Style
References
- National Library of Medicine. Metformin. Medical Subject Headings (MeSH). 2026. Unique ID D008687. http://id.nlm.nih.gov/mesh/2026/D008687
- Metformin. In: Wikipedia. https://en.wikipedia.org/wiki/Metformin
- Metformin. In: Wikidata. https://www.wikidata.org/wiki/Q19484